Form 4: Eli Lilly EVP, GC & Secretary Anat Hakim Reports Acquisition of Shares and Restricted Stock Units
SEC Form 4 Filing
Anat Hakim, EVP, GC & Secretary of Eli Lilly & Co, reports acquiring shares and restricted stock units, increasing her direct and indirect beneficial ownership.
Summary
- On February 10, 2025, Anat Hakim, EVP, GC & Secretary of Eli Lilly & Co, acquired 10,320.956 shares of common stock at a price of $868.88 per share.
- Following this transaction, Hakim directly owns 28,837.5 shares of Eli Lilly common stock.
- Hakim also indirectly owns 14,700 shares through Anat Hakim SLAT.
- Additionally, Hakim acquired 6,700 restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock, exercisable on February 1, 2026, and expiring on February 1, 2026.
- Following the transaction, Hakim directly owns 6,700 restricted stock units.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The acquisition of shares by an executive is generally viewed positively, but the form itself is simply a reporting requirement.
Positives
- The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is important for maintaining market confidence.
Comparison to Industry Standards
- Executive stock ownership is a common practice among publicly traded companies like Eli Lilly, Pfizer, and Merck.
- These companies often use stock options and restricted stock units as part of their compensation packages to align executive interests with shareholder value.
- The amount of stock and restricted stock units held by executives varies depending on their role, tenure, and company performance.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding the executive's stake in the company.
- The acquisition of shares by a key executive could positively influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Date of transaction for common stock and restricted stock units acquisition. |
| 02/01/2026 | Exercisable and expiration date for restricted stock units. |
| 02/12/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.